# NADOLOL AND BENDROFLUMETHIAZIDE
> **ANDA078688** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA · Approved 2008-02-15
## Drug
- **FDA Application Number:** ANDA078688
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NADOLOL AND BENDROFLUMETHIAZIDE
- **Generic name:** Bendroflumethiazide
- **Active ingredients:** BENDROFLUMETHIAZIDE; NADOLOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NATCO PHARMA
- **First approval:** 2008-02-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078688)
---
*MORVS · CC0 1.0*